Graft Versus Host Disease
Cyclophosphamide for Preventing Graft-Versus-Host Disease (FHCRC-2541)
A Phase II Study to Evaluate the Efficacy of Posttransplant Cyclophosphamide for Prevention of Chronic Graft-versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation
Investigator: Marco Mielcarek, MD; Conditions: Chronic Graft Versus Host Disease (cGVHD); Status: Recruiting; Study ID: NCT01427881
A Randomized Phase 2 Study of Imatinib and Rituximab for Cutaneous Sclerosis in Patients with Chronic Graft-Versus-Host Disease
Investigator: Mary Flowers, MD; Conditions: Chronic Graft Versus Host Disease (cGVHD); Status: Recruiting; Study ID: NCT01309997
A Phase II, Open-Label, Multi-Center Study to Assess the Safety and Efficacy of Alefacept in Subjects with Steroid-Refractory Chronic Graft-versus-Host Disease
Investigator: Stephanie Lee, MD, MPH; Conditions: Chronic Graft Versus Host Disease (cGVHD); Status: Closed; Study ID: NCT01226420
A Multi-Center Study of Nonmyeloablative Conditioning with TBI or Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies with Post Grafting Immunosuppression with Tacrolimus and Mycophenolate Mofetil
Investigator: David Maloney, MD, PhD; Conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases; Status: Recruiting; Study ID: NCT00089011
A Phase II/III Randomized, Multicenter Trial Comparing Sirolimus plus Prednisone, Sirolimus/Extracorporeal Photopheresis plus Prednisone, and Sirolimus/Calcineurin Inhibitor plus Prednisone for the Treatment of Chronic Graft-versus-Host Disease (BMT CTN 0801)
Investigator: Paul Carpenter, MD; Conditions: Bone Marrow and Hematopoietic Stem Cell Transplant (BMT and HSCT); Status: Recruiting; Study ID: NCT01106833
A Phase 1 Study of Nilotinib in Steroid Dependent / Refractory Chronic Graft Versus Host Disease
Investigator: Paul Carpenter, MD; Conditions: Chronic Graft Versus Host Disease (cGVHD); Status: Recruiting; Study ID: NCT01155817
A Phase II Study to Assess Immunosuppression with Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate mofetil (MMF) for Prevention of Acute GVHD after Non-myeloablative HLA Class I or II Mismatched Donor Hematopoietic Cell Transplantation. A Multi-Center Trial
Investigator: Brenda Sandmaier, MD; Conditions: Hematologic Malignancies; Status: Recruiting; Study ID: NCT01251575
A Randomized Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD after Unrelated Donor Hematopoietic Cell Transplantation using Nonmyeloablative Conditioning for Patients with Hematologic Malignancies: A Multi-Center Trial
Investigator: Brenda Sandmaier, MD; Conditions: Hematologic Malignancies; Status: Recruiting; Study ID: NCT01231412
Pentostatin and Donor Lymphocyte Infusion for Low Donor T-Cell Chimerism After Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning - A Multicenter Trial
Investigator: Brenda Sandmaier, MD; Conditions: Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphoid Leukemia (CLL), Chronic Myeloid Leukemia (CML), Hematologic Malignancies, Hodgkin's Lymphoma, Leukemia, Lymphoma, Multiple Myeloma (MM), Myelodysplastic and Myeloproliferative Syndromes (MDS and MPD), Non-Hodgkin's Lymphoma (NHL); Status: Recruiting; Study ID: NCT00096161
A Multi-center Phase II Study of Selective Depletion of CD45RA+ T cells from Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Investigator: Marie Bleakley, MD; Conditions: Acute Lymphoid Leukemia (ALL);, Acute Myeloid Leukemia (AML), Hematologic Malignancies, Myelodysplastic Syndromes (MDS) Myeloproliferative Syndromes (MPD); Status: Recruiting; Study ID: NCT00914940
A Randomized Trial Of Sirolimus-Based Graft Versus Host Disease Prophylaxis After Hematopoietic Stem Cell Transplant
Investigator: Jean Sanders, MD; Conditions: Graft Versus Host Disease, Leukemia; Status: Closed; Study ID: NCT00382109
Multi-Institutional Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic Stem Cell Transplantation in Children and Adults
Investigator: Paul Martin, MD; Conditions: Bronchiolitis Obliterans, Chronic Graft-versus-host Disease; Status: Recruiting; Study ID: NCT00656058
Fluticasone Propionate, Azithromycin, and Montelukast Sodium in Treating Patients With Bronchiolitis Obliterans Who Previously Underwent Stem Cell Transplant
Investigator: Paul Martin, MD; Conditions: Chronic Graft Versus Host Disease (cGVHD); Status: Recruiting; Study ID: NCT01307462
A Phase III Study to Assess Efficacy and Safety of Low-Dose Glucocorticoids for Initial Treatment of Acute Graft-versus-Host Disease
Investigator: Marco Mielcarek, MD; Conditions: Graft Versus Host Disease; Status: Recruiting; Study ID: NCT00929695
Treatment of steroid non-responsive acute GVHD with alpha 1 anti-trypsin (AAT). A phase I/II study.
Investigator: Joachim Deeg, MD; Conditions: Graft Versus Host Disease; Status: Closed; Study ID: NCT01523821
Phase II Study to Evaluate the Efficacy of Brentuximab Vedotin in Patients with Steroid-Resistant Acute GVHD
Investigator: Merav Bar, MD; Conditions: Chronic Graft Versus Host Disease (cGVHD); Status: Recruiting; Study ID: NCT01616680
A Randomized Placebo Controlled Double-Blind Study of Restasis® Versus Placebo in Primary Prevention of Ocular GVHD After Allogeneic Stem Cell Transplantation
Investigator: Mary Flowers, MD; Conditions: Chronic Graft Versus Host Disease (cGVHD); Status: Recruiting; Study ID: NCT00755040
A Phase II Trial of Daily Low-Dose Interleukin-2 (IL-2) for Steroid-Refractory Chronic Graft-Versus-Host-Disease
Investigator: Stephanie Lee, MD, MPH; Conditions: Chronic Graft Versus Host Disease (cGVHD); Status: Recruiting; Study ID: NCT01366092
Join Us On